Royals infielder Miguel Tejada was handed a 105-game suspension from MLB over the weekend following multiple positive tests for amphetamine use, but Pedro Gomez of ESPN.com reports that the former American League MVP was also implicated in the recent Biogenesis investigation. In fact, it appears MLB leveraged his link to Biogenesis to get him to drop an appeal on his 105-game suspension.
Major League Baseball had the choice of going after the 2002 American League MVP for the Biogenesis case, as the league did 13 other players earlier this month, or for the amphetamine case. MLB chose to suspend Tejada after he tested positive for a third time in his career for amphetamines.
Tejada, according to a source familiar with the case, was given the choice of either accepting the 105-game suspension for amphetamine use or facing additional punishment for his Biogenesis connection. Tejada was allegedly a customer of Tony Bosch’s shuttered clinic, which is at the heart of baseball’s recent rash of suspensions. Bosch supplied evidence that Tejada had been a Biogenesis customer.
Tejada has been linked to performance-enhancing drugs dating back to the Mitchell Report and plead guilty to misleading Congress back in 2009. He admitted to purchasing human growth hormone (HGH) in the past, but claimed that he threw the drugs away before injecting them. It’s not clear what he may have purchased from Biogenesis, but any denials are going to ring pretty hollow at this point.
The Royals recently moved Tejada to the 60-day disabled list following a calf strain, so his season was essentially over anyway, but the suspension will also knock him out of commission for the first 64 games in 2014. The 39-year-old has insisted that he doesn’t plan to retire, but there’s a real chance that we have seen the last of him in the majors.